The Effects of Hepatogomax Enteral Formula on Systemic Inflammation, Caecum Short-Chain Fatty Acid Levels, and Liver Histopathology in Thioacetamide-Induced Rats

Table 3

SCFA levels after intervention.

SCFA (m Mol)	Mean ± SD						^1
	K1	K2	K3	P1	P2	P3
Acetic acid	4.29 ± 0.77^a,b	1.85 ± 0.48^a,b	2.11 ± 0.77^a,b	2.20 ± 0.46^a,b	2.18 ± 0.75^a,b	3.13 ± 0.97^a,b	<0.001
Propionic acid	3.09 ± 0.60^a,b	1.54 ± 0.33^a,b	1.75 ± 0.58^a,b	1.81 ± 0.43^a,b	1.84 ± 0.62^a,b	2.54 ± 0.68^a,b	<0.001
Butyric acid	1.46 ± 0.27^a,b	0.78 ± 0.19^a,b	0.90 ± 0.29^a,b	0.92 ± 0.20^a,b	0.95 ± 0.25^a	1.25 ± 0.32^a,b	0.001

¹One-way ANOVA test;  =  value; significant difference ( < 0.05); ^asignificant difference against control group (post hoc LSD test); ^bsignificant difference against intervention group (post hoc LSD test).